TP53 and breast carcinoma: Germline mutations in the TP53 gene are responsible for Li–Fraumeni syndrome, which is characterized by autosomal dominant inheritance and early onset of a wide range of tumor types, including soft tissue sarcomas and osteosarcomas, breast cancer, brain tumors, leukemia, and adrenocortical carcinoma.